Cargando…

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

BACKGROUND: The efficacy and safety of minimisation of immunosuppression including early steroid withdrawal in kidney transplant recipients treated with Basiliximab induction remains unclear. METHODS: This retrospective cohort study reports the outcomes from 298 consecutive renal transplants perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phanish, Mysore K., Hull, Richard P., Andrews, Peter A., Popoola, Joyce, Kingdon, Edward J., MacPhee, Iain A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065371/ https://www.ncbi.nlm.nih.gov/pubmed/32160893 http://dx.doi.org/10.1186/s12882-020-01739-3

Ejemplares similares

Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)

COVID-19 infection in kidney transplant recipients
por: Banerjee, Debasish, et al.
Publicado: (2020)

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
por: Abboudi, Hamid, et al.
Publicado: (2012)

Systematic Review and Meta-analysis of COVID-19 and Kidney Transplant Recipients, the South West London Kidney Transplant Network Experience
por: Phanish, Mysore, et al.
Publicado: (2020)

Should prospective renal transplant recipients be screened for Strongyloides stercoralis?
por: Arkell, Paul, et al.
Publicado: (2020)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation
por: Phanish, M. K.
Publicado: (2016)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Xenobiotic Metabolism: The Effect of Acute Kidney Injury on Non-Renal Drug Clearance and Hepatic Drug Metabolism
por: Dixon, John, et al.
Publicado: (2014)

Sequence balance minimisation: minimising with unequal treatment allocations
por: Madurasinghe, Vichithranie W.
Publicado: (2017)

Fundamentos de parodoncia /
por: MacPhee, Torquil
Publicado: (1989)

Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
por: Sigurjonsdottir, Vaka K., et al.
Publicado: (2022)

Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial
por: Stringer, Dominic, et al.
Publicado: (2023)

Phosphoserine-86-HSPB1 (pS86-HSPB1) is cytoplasmic and highly induced in rat myometrium at labour
por: Miskiewicz, E. I., et al.
Publicado: (2022)

Immunologic monitoring in kidney transplant recipients
por: Townamchai, Natavudh, et al.
Publicado: (2013)

Estimated Glomerular Filtration Rate Correlates Poorly with Four-Hour Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury
por: Kirwan, Christopher J., et al.
Publicado: (2013)

The Nursing Leadership Institute program evaluation: a critique
por: Havaei, Farinaz, et al.
Publicado: (2015)

The impact of heavy nurse workload and patient/family complaints on workplace violence: An application of human factors framework
por: Havaei, Farinaz, et al.
Publicado: (2020)

An investigation of minimisation criteria
por: Wade, Angie, et al.
Publicado: (2006)

Minimising byte swapping
por: Poppe, M
Publicado: (1986)

Chest pain and pseudoclubbing in a haemodialysis patient
por: Winn, Simon, et al.
Publicado: (2008)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Malignant and Noninvasive Skin Tumours in Renal Transplant Recipients
por: Roche, Christopher D., et al.
Publicado: (2014)

Waste minimisation : a chemist's approach /
Publicado: (1994)

Membrainy: a ‘smart’, unified membrane analysis tool
por: Carr, Matthew, et al.
Publicado: (2015)

Moving Forward With Integrated Care: The Use of Realist Approaches to Understand What Works, How, for Whom and Under Which Circumstances
por: Peytremann-Bridevaux, Isabelle, et al.
Publicado: (2022)

Smad Mediated Regulation of Inhibitor of DNA Binding 2 and Its Role in Phenotypic Maintenance of Human Renal Proximal Tubule Epithelial Cells
por: Veerasamy, Mangalakumar, et al.
Publicado: (2013)

Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy
por: Manzia, Tommaso Maria, et al.
Publicado: (2023)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jur5gcop95ajdpiggmsa4lhp9t